Perceptive Advisors LLC Verona Pharma PLC Transaction History
Perceptive Advisors LLC
- $2.28 Billion
- Q2 2025
A detailed history of Perceptive Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Perceptive Advisors LLC holds 5,507,591 shares of VRNA stock, worth $579 Million. This represents 22.87% of its overall portfolio holdings.
Number of Shares
5,507,591
Previous 6,563,340
16.09%
Holding current value
$579 Million
Previous $417 Million
25.01%
% of portfolio
22.87%
Previous 17.44%
Shares
20 transactions
Others Institutions Holding VRNA
# of Institutions
322Shares Held
76.8MCall Options Held
970KPut Options Held
3.13M-
Janus Henderson Group PLC London, X06.13MShares$645 Million0.3% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y94.13MShares$434 Million16.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$356 Million16.88% of portfolio
-
Rtw Investments, LP New York, NY3.05MShares$321 Million4.43% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.72MShares$286 Million4.88% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.41B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...